cardiovascular diseases

You have accessRestricted Access
IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD
Adriana M. Hung, Yohei Tsuchida, Kristen L. Nowak, Sudipa Sarkar, Michel Chonchol, Victoria Whitfield, Natjalie Salas, Anna Dikalova, Patricia G. Yancey, Jiansheng Huang, MacRae F. Linton, T. Alp Ikizler and Valentina Kon

CJASN April 2019, CJN.04360418; DOI: https://doi.org/10.2215/CJN.04360418

Add to Selected Citations
You have accessRestricted Access
Fruit and Vegetable Intake and Mortality in Adults undergoing Maintenance Hemodialysis
Valeria M. Saglimbene, Germaine Wong, Marinella Ruospo, Suetonia C. Palmer, Vanessa Garcia-Larsen, Patrizia Natale, Armando Teixeira-Pinto, Katrina L. Campbell, Juan-Jesus Carrero, Peter Stenvinkel, Letizia Gargano, Angelo M. Murgo, David W. Johnson, Marcello Tonelli, Rubén Gelfman, Eduardo Celia, Tevfik Ecder, Amparo G. Bernat, Domingo Del Castillo, Delia Timofte, Marietta Török, Anna Bednarek-Skublewska, Jan Duława, Paul Stroumza, Susanne Hoischen, Martin Hansis, Elisabeth Fabricius, Paolo Felaco, Charlotta Wollheim, Jörgen Hegbrant, Jonathan C. Craig and Giovanni F.M. Strippoli

CJASN February 2019, 14 (2) 250-260; DOI: https://doi.org/10.2215/CJN.08580718

Add to Selected Citations
Open Access
Patterns of Beverages Consumed and Risk of Incident Kidney Disease
Casey M. Rebholz, Bessie A. Young, Ronit Katz, Katherine L. Tucker, Teresa C. Carithers, Arnita F. Norwood and Adolfo Correa

CJASN January 2019, 14 (1) 49-56; DOI: https://doi.org/10.2215/CJN.06380518

Add to Selected Citations
You have accessRestricted Access
Sleep Quality and Sleep Duration with CKD are Associated with Progression to ESKD
Ryohei Yamamoto, Maki Shinzawa, Yoshitaka Isaka, Etsuko Yamakoshi, Enyu Imai, Yasuo Ohashi, Akira Hishida and for the CKD-JAC Investigators

CJASN December 2018, 13 (12) 1825-1832; DOI: https://doi.org/10.2215/CJN.01340118

Add to Selected Citations
You have accessRestricted Access
ACCORDION: Ensuring That We Hear the Music Clearly
Muh Geot Wong, Hiddo J.L. Heerspink and Vlado Perkovic

CJASN November 2018, 13 (11) 1621-1623; DOI: https://doi.org/10.2215/CJN.11370918

Add to Selected Citations
You have accessRestricted Access
Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes
Amy K. Mottl, John B. Buse, Faramarz Ismail-Beigi, Ronald J. Sigal, Carolyn F. Pedley, Vasilios Papademetriou, Debra L. Simmons, Lois Katz, Josyf C. Mychaleckyj and Timothy E. Craven

CJASN November 2018, 13 (11) 1693-1702; DOI: https://doi.org/10.2215/CJN.06200518

Add to Selected Citations
You have accessRestricted Access
Microbiome and Cardiovascular Disease in CKD
Anna Jovanovich, Tamara Isakova and Jason Stubbs

CJASN October 2018, 13 (10) 1598-1604; DOI: https://doi.org/10.2215/CJN.12691117

Add to Selected Citations
Open Access
Clinical Pharmacogenomics
Solomon M. Adams, Karryn R. Crisamore and Philip E. Empey

CJASN October 2018, 13 (10) 1561-1571; DOI: https://doi.org/10.2215/CJN.02730218

Add to Selected Citations
Open Access
Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease
Carmine Zoccali and Francesca Mallamaci

CJASN September 2018, 13 (9) 1432-1434; DOI: https://doi.org/10.2215/CJN.01360118

Add to Selected Citations
Open Access
Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease
Wolfgang C. Winkelmayer

CJASN September 2018, 13 (9) 1423-1425; DOI: https://doi.org/10.2215/CJN.06270518

Add to Selected Citations

Main menu

User menu

Search

cardiovascular diseases

Pages

About

Author Information

More information